Our results are consistent with these studies identifying ZFP36L1 as a tumor suppressor in SCLC, where it also possesses the ability to bind and downregulate mRNAs that promote SCLC neuroendocrine differentiation including INSM1 and SOX2. The gene discussed is ZFP36L1; the disease is neoplasm.